Benign & Malignant - An Overview
- The cardinal principle is that a foot or ankle mass is MALIGNANT UNTIL PROVEN OTHERWISE: malignant tumours here are rare and are frequently MISDIAGNOSED as benign (a 'ganglion', wart or callus), which leads to inadequate, unplanned excision and poor outcomes - so any soft-tissue mass that is solid, enlarging, deep to fascia, fixed, painful, or larger than a few centimetres must be properly worked up before any surgery.
- Most foot lumps ARE benign - ganglion (the commonest), plantar fibroma (Ledderhose disease), giant-cell tumour of the tendon sheath, synovial chondromatosis, lipoma and nerve sheath tumours - but the benign label must be earned by appropriate assessment, not assumed from the location or a soft history.
- The commonest soft-tissue SARCOMA of the foot is SYNOVIAL SARCOMA; it can be small and relatively slow-growing, sits near joints/tendons, may calcify, and is a classic lesion to be mistaken for a ganglion and excised unplanned - the commonest primary bony malignancy of the foot is OSTEOSARCOMA, with Ewing sarcoma and chondrosarcoma also occurring.
- The correct PATHWAY is IMAGE then BIOPSY then REFER, all BEFORE definitive excision: plain radiographs for the bone, MRI for the soft tissue and local extent, staging where malignancy is suspected, and a properly PLANNED biopsy (placed so the tract can be excised en bloc with the tumour, ideally performed at or in discussion with the unit that will do the definitive surgery).
- An UNPLANNED ('whoops') EXCISION - removing a presumed-benign mass that turns out to be a sarcoma without margins - is a recognised catastrophe: according to PubMed, unplanned initial surgery of malignant foot/ankle tumours is associated with significantly HIGHER local RECURRENCE (about 50% vs about 22%) and worse outcomes than planned surgery, and reinforces referral to a specialist tumour centre.
- MANAGEMENT therefore depends on the diagnosis: benign symptomatic lesions are treated on their own merits (e.g. excision of a symptomatic GCT of tendon sheath, marginal excision of a problematic plantar fibroma with its recurrence risk), whereas malignancy requires multidisciplinary care with wide excision (often demanding in the foot, sometimes amputation/ray amputation) plus chemotherapy/radiotherapy as indicated - the single most important orthopaedic responsibility is to NOT excise an unknown mass unplanned.
- “A foot/ankle mass is MALIGNANT UNTIL PROVEN OTHERWISE - solid, enlarging, deep, fixed, painful, or larger than a few cm = work it up before any surgery. Synovial sarcoma is the classic 'looks-like-a-ganglion' trap.
- “Pathway = IMAGE (XR + MRI, stage) -> properly-PLANNED BIOPSY (excisable tract) -> REFER to a tumour unit -> definitive surgery. Never the unplanned 'whoops' excision.
- “Commonest soft-tissue sarcoma of foot = synovial sarcoma; commonest bony malignancy = osteosarcoma. Unplanned excision ~doubles local recurrence (~50% vs ~22%).
A small foot mass excised as a 'ganglion' that proves to be a synovial sarcoma - now there is tumour in the wound, contaminated planes, and a far harder, often mutilating, re-resection.
Malignant until proven otherwise. Image (XR + MRI), then a planned biopsy with an excisable tract, then refer to a tumour unit - all before any excision. Earn the benign label.
The Spectrum - Benign vs Malignant
| Category | Examples | Notes |
|---|---|---|
| Benign soft tissue | Ganglion, plantar fibroma (Ledderhose), GCT of tendon sheath, synovial chondromatosis, lipoma, schwannoma | Common; ganglion is commonest; plantar fibroma recurs after marginal excision |
| Benign bone | Simple/aneurysmal bone cyst, osteochondroma, enchondroma, osteoid osteoma, subungual exostosis | Calcaneus a common cyst site; treat on own merits |
| Malignant soft tissue | Synovial sarcoma (commonest), other sarcomas; SCC, melanoma (acral/subungual) | Synovial sarcoma small/near joints/may calcify - classic 'ganglion' mimic |
| Malignant bone | Osteosarcoma (commonest), Ewing sarcoma, chondrosarcoma | Rare; acrometastasis (metastasis to foot) very rare |
Re-think a 'benign' label if the mass is: solid (not transilluminating), deep to fascia, fixed, enlarging, painful, larger than a few centimetres, recurs after a previous 'ganglion' excision, or shows calcification/bone destruction on imaging. Any of these mandates MRI and a planned biopsy before surgery.
The Safe Pathway: Image -> Biopsy -> Refer
- Image: plain radiographs (bone, calcification, periosteal reaction) and MRI (soft-tissue characterisation and local extent); stage (chest CT, etc.) when malignancy is suspected.
- Biopsy - properly planned: the biopsy tract must be placed so it can be excised en bloc with the tumour at definitive surgery; ideally performed at, or after discussion with, the tumour unit that will do the definitive resection - a poorly placed biopsy can compromise limb salvage.
- Refer: suspected malignancy goes to a specialist sarcoma/tumour unit for multidisciplinary management.
- Then treat: benign symptomatic lesions on their merits; malignancy with wide excision (technically demanding in the foot; sometimes ray amputation/amputation) plus chemotherapy/radiotherapy as indicated.
The single most important orthopaedic responsibility with a foot or ankle mass is to NOT perform an unplanned excision of an undiagnosed lesion. Malignant foot tumours are rare and easily mistaken for benign lumps, and removing one without a diagnosis and without margins contaminates the surgical field, mandates a far more extensive re-resection, and - as shown in published series - is associated with a markedly higher local recurrence rate and worse outcome than a planned, margin-controlled operation. If you are not certain a mass is benign, image it, biopsy it properly (or refer for biopsy), and involve a tumour unit before any definitive surgery. Earn the benign label; do not assume it.
Evidence & Key Studies
Malignant bone and soft-tissue lesions of the foot
- Malignant tumours of the foot are rare and, because of their rarity, are often misdiagnosed - resulting in inadequate (unplanned) excision and poor outcomes.
- A correct approach with careful clinical examination and radiological study, followed by a properly performed biopsy, is mandatory to avoid these pitfalls.
- The review covers the clinicopathological presentation, imaging features and current treatment of the common malignant bone and soft-tissue lesions of the foot, including synovial sarcoma.
Malignant tumors of the foot and ankle - unplanned surgery worsens outcome
- In 80 malignant foot/ankle tumours, synovial sarcoma was the most common soft-tissue tumour and osteosarcoma the most common osseous tumour; most arose from soft tissue (78%).
- Unplanned initial surgery (excision without prior biopsy at an outside institution) was associated with a higher local recurrence rate (50% vs 22%) and higher mortality (10% vs 6%) than planned surgery.
- The authors reinforce that these patients should be referred for treatment at a centre with specialised expertise in tumour management.
According to PubMed, the rarity and frequent misdiagnosis of malignant foot tumours and the mandatory exam-imaging-biopsy approach come from the cited Angelini review, and the worse outcomes of unplanned ('whoops') excision (about 50% vs 22% local recurrence; higher mortality) with the recommendation to refer to a specialist tumour centre from the cited Karaca series. The benign vs malignant spectrum and the principle that a foot mass is malignant until proven otherwise are standard, well-established teaching. (See also our Synovial Sarcoma, Plantar Fibromatosis, Aneurysmal Bone Cyst, Osteochondroma, Subungual Exostosis and Biopsy Principles topics.)
Clinical Decision Scenarios
Practise clinical reasoning and management decisions out loud
“A patient is referred with a 3 cm firm lump on the dorsum of the foot that the GP thinks is a ganglion. How do you approach it?”
Mnemonics & Memory Aids
WHOOPS
Hook:WHOOPS - the unplanned excision is what you must avoid: Watch red flags, Hold the knife, Obtain imaging, Organise a planned biopsy, Pass to a unit, remember Synovial sarcoma.
Principle
- A foot/ankle mass is MALIGNANT until proven otherwise
- Malignant lesions are rare and frequently misdiagnosed as benign
- Earn the benign label by proper assessment - don't assume it
Commonest lesions
- Benign: ganglion (commonest), plantar fibroma, GCT of tendon sheath, cysts, osteochondroma
- Malignant soft tissue: synovial sarcoma (commonest) - the classic ganglion mimic
- Malignant bone: osteosarcoma (commonest), Ewing, chondrosarcoma
Safe pathway
- Image: radiograph + MRI; stage if malignancy suspected
- Planned biopsy: tract excisable en bloc; do/discuss at the tumour unit
- Refer to a specialist sarcoma centre before definitive surgery
Why it matters
- Unplanned 'whoops' excision ~doubles local recurrence (~50% vs ~22%)
- And worsens mortality vs planned surgery
- Definitive malignant care = wide excision +/- chemo/radiotherapy (MDT)